Literature DB >> 9372267

Measurements of catecholamine-mediated apoptosis of immunocompetent cells by capillary electrophoresis.

J Bergquist1, E Josefsson, A Tarkowski, R Ekman, A Ewing.   

Abstract

Single cell analysis with capillary electrophoresis, a technique capable of detecting zeptomole quantities (10(-21) mole) of neurochemical species, has been used to demonstrate that lymphocytes are capable of active synthesis of dopamine and norepinephrine. Exposure of lymphocytes to catecholamines at concentrations as low as 10 nM leads to decreased proliferation and differentiation, e.g. interferon-gamma (IFN-gamma), interleukin-4 (IL-4) and immunoglobulin (Ig). In addition, both inhibition of dopamine uptake with nomifensine and inhibition of packing of catecholamines into vesicles with tetrabenazine, results in significantly lower levels of dopamine and norepinephrine (p < 0.01 and p < 0.05, respectively). The catecholamine-dependent inhibition of T- and B-lymphocyte activity is mediated via an induction of a Bcl-2/Bax and Fas/FasL involved apoptosis. These findings indicate a novel mechanism for regulation of lymphocyte activity in the central nervous system, whereby elevated regional levels of catecholamines might lead to the immunoprivilege of the brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372267     DOI: 10.1002/elps.1150181009

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  20 in total

1.  Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment.

Authors:  F Magro; E Cunha; F Araujo; E Meireles; P Pereira; M Dinis-Ribeiro; F Tavarela Veloso; R Medeiros; P Soares-da-Silva
Journal:  Dig Dis Sci       Date:  2006-09-15       Impact factor: 3.199

2.  Secondary ion MS imaging to relatively quantify cholesterol in the membranes of individual cells from differentially treated populations.

Authors:  Sara G Ostrowski; Michael E Kurczy; Thomas P Roddy; Nicholas Winograd; Andrew G Ewing
Journal:  Anal Chem       Date:  2007-04-12       Impact factor: 6.986

3.  Control of the release of freely diffusing molecules in single-cell electroporation.

Authors:  Aparna Agarwal; Manyan Wang; Jessica Olofsson; Owe Orwar; Stephen G Weber
Journal:  Anal Chem       Date:  2009-10-01       Impact factor: 6.986

4.  D1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in jurkat T leukemic cells.

Authors:  Biswarup Basu; Chandrani Sarkar; Debanjan Chakroborty; Subhalakshmi Ganguly; Saurav Shome; Partha Sarathi Dasgupta; Sujit Basu
Journal:  J Biol Chem       Date:  2010-06-30       Impact factor: 5.157

Review 5.  The role of the sympathetic nervous system in intestinal inflammation.

Authors:  R H Straub; R Wiest; U G Strauch; P Härle; J Schölmerich
Journal:  Gut       Date:  2006-11       Impact factor: 23.059

Review 6.  Dopamine, T cells and multiple sclerosis (MS).

Authors:  Mia Levite; Franca Marino; Marco Cosentino
Journal:  J Neural Transm (Vienna)       Date:  2017-03-10       Impact factor: 3.575

7.  Cytokine analysis by immunoaffinity capillary electrophoresis.

Authors:  Mark Mendonca; Heather Kalish
Journal:  Methods Mol Biol       Date:  2013

8.  Separation and characterization of amines from individual atrial gland vesicles of Aplysia californica.

Authors:  S J Lillard; D T Chiu; R H Scheller; R N Zare; S E Rodríguez-Cruz; E R Williams; O Orwar; M Sandberg; J A Lundqvist
Journal:  Anal Chem       Date:  1998-09-01       Impact factor: 6.986

9.  Upregulation of phagocyte-derived catecholamines augments the acute inflammatory response.

Authors:  Michael A Flierl; Daniel Rittirsch; Brian A Nadeau; J Vidya Sarma; Danielle E Day; Alex B Lentsch; Markus S Huber-Lang; Peter A Ward
Journal:  PLoS One       Date:  2009-02-12       Impact factor: 3.240

Review 10.  Catecholamines-crafty weapons in the inflammatory arsenal of immune/inflammatory cells or opening pandora's box?

Authors:  Michael A Flierl; Daniel Rittirsch; Markus Huber-Lang; J Vidya Sarma; Peter A Ward
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.